Основная статистика
| CIK | 1813914 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CareMax, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39391 CareMax, Inc. (Exact name of registrant as specified in its chart |
|
| February 3, 2025 |
As filed with the U.S. Securities and Exchange Commission on February 3, 2025. As filed with the U.S. Securities and Exchange Commission on February 3, 2025. Registration No. 333-257574 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 8000 85-0992224 (State or other jurisdiction |
|
| February 3, 2025 |
As filed with the Securities and Exchange Commission on February 3, 2025 As filed with the Securities and Exchange Commission on February 3, 2025 Registration No. |
|
| February 3, 2025 |
Exhibit 16.1 February 3, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by CareMax, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of CareMax, Inc. dated January 30, 2025. We agree with the statements concerning our Firm contained |
|
| February 3, 2025 |
Case 24-80093-mvl11 Doc 576 Filed 01/30/25 Entered 01/30/25 22:54:25 Desc Exhibit 99.1 Case 24-80093-mvl11 Doc 576 Filed 01/30/25 Entered 01/30/25 22:54:25 Desc Main Document Page 1 of 15 SIDLEY AUSTIN LLP Thomas R. Califano (24122825) Juliana L. Hoffman (24106103) 2021 McKinney Avenue, Suite 2000 Dallas, Texas 75201 Telephone: (214) 981-3300 Facsimile: (214) 981-3400 Email: [email protected] [email protected] SIDLEY AUSTIN LLP Stephen Hessler (admitted pro hac |
|
| February 3, 2025 |
Exhibit 99.2 Case 24-80093-mvl11 Doc 577 Filed 01/30/25 Entered 01/30/25 23:00:15 Desc Main Document Page 1 of 15 SIDLEY AUSTIN LLP Thomas R. Califano (24122825) Juliana L. Hoffman (24106103) 2021 McKinney Avenue, Suite 2000 Dallas, Texas 75201 Telephone: (214) 981-3300 Facsimile: (214) 981-3400 Email: [email protected] [email protected] SIDLEY AUSTIN LLP Stephen Hessler (admitted pro hac |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2025 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 3, 2025 |
As filed with the Securities and Exchange Commission on February 3, 2025 As filed with the Securities and Exchange Commission on February 3, 2025 Registration Nos. |
|
| February 3, 2025 |
As filed with the Securities and Exchange Commission on February 3, 2025 As filed with the Securities and Exchange Commission on February 3, 2025 Registration Nos. |
|
| February 3, 2025 |
Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION In re: Chapter 11 CAREMAX, INC., et al.1 Case No. 24-80093 (MVL) Debtors. (Jointly Administered) FINDINGS OF FACT, CONCLUSIONS OF LAW, AND ORDER (I) APPROVING THE DEBTORS’ DISCLOSURE STATEMENT ON A FINAL BASIS; AND (II) CONFIRMING THE THIRD AMENDED JOINT CHAPTER 11 PLAN OF CAREMAX, INC. AND |
|
| January 3, 2025 |
Case 24-80093-mvl11 Doc 332 Filed 12/29/24 Entered 12/29/24 19:34:35 Desc Main Document Page 1 of 15 Exhibit 99.1 Case 24-80093-mvl11 Doc 332 Filed 12/29/24 Entered 12/29/24 19:34:35 Desc Main Document Page 1 of 15 SIDLEY AUSTIN LLP Thomas R. Califano (24122825) Juliana L. Hoffman (24106103) 2021 McKinney Avenue, Suite 2000 Dallas, Texas 75201 Telephone: (214) 981-3300 Facsimile: (214) 981-3400 Email: [email protected] [email protected] SIDLEY AUSTIN LLP Stephen Hessler (admitted pro hac |
|
| January 3, 2025 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| January 3, 2025 |
Case 24-80093-mvl11 Doc 359 Filed 01/02/25 Entered 01/02/25 14:35:57 Desc Main Document Page 1 of 15 Exhibit 99.2 Case 24-80093-mvl11 Doc 359 Filed 01/02/25 Entered 01/02/25 14:35:57 Desc Main Document Page 1 of 15 SIDLEY AUSTIN LLP Thomas R. Califano (24122825) Juliana L. Hoffman (24106103) 2021 McKinney Avenue, Suite 2000 Dallas, Texas 75201 Telephone: (214) 981-3300 Facsimile: (214) 981-3400 Email: [email protected] [email protected] SIDLEY AUSTIN LLP Stephen Hessler (admitted pro hac |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 25, 2024 |
Exhibit 99.1 CareMax Enters Into Agreement to Sell Core Centers’ Assets ClareMedica Health Partners to become “Stalking Horse” Bidder to Acquire CareMax’s Core Centers’ Assets MIAMI – November 25, 2024 – CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced that it has entered into a “stalking horse” purchas |
|
| November 25, 2024 |
Exhibit 2.1 Execution Version ASSET PURCHASE AGREEMENT BY AND AMONG CLAREMEDICA VIKING, LLC, CLAREMEDICA PARENT HOLDINGS, LP, AND CAREMAX, INC. November 24, 2024 TABLE OF CONTENTS Page Article I THE TRANSACTION 2 1.01 Basic Transaction 2 1.02 No Liabilities 2 1.03 Closing Payment 3 1.04 Withholding 3 Article II CLOSING DELIVERABLES 3 2.01 Closing 3 2.02 Buyer’s Closing Deliverables 4 2.03 Seller P |
|
| November 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 18, 2024 |
CareMax, Inc. 1000 NW 57 Court, Suite 400 Miami, FL 33126 Exhibit 10.5 CareMax, Inc. 1000 NW 57 Court, Suite 400 Miami, FL 33126 November 15, 2024 Mr. Kevin Wirges Dear Kevin: Given your position as Chief Financial Officer of CareMax, Inc. (the “Company”), you are key to the Company’s business and your continued employment is important to the Company’s future success. For purposes of this letter agreement (the “Agreement”), references to the “Company” sh |
|
| November 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 18, 2024 |
RESTRUCTURING SUPPORT AGREEMENT Exhibit 10.1 Execution Version THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER OR ACCEPTANCE WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 PLAN WITHIN THE MEANING OF SECTION 1125 OF THE BANKRUPTCY CODE. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR PROVISIONS OF THE BANKRUPTCY CODE. NOTHING CONTAINED IN THIS RESTRUCTURI |
|
| November 18, 2024 |
Exhibit 10.3 Execution Version SECURITIES PURCHASE AGREEMENT BY AND AMONG RHG NETWORK, LLC, SPARTA MERGER SUB I LLC, SPARTA MERGER SUB II LLC, AND CAREMAX, INC. November 17, 2024 Table of Contents Page Article I THE TRANSACTION 2 1.01 Basic Transaction 2 1.02 Purchase Price 2 1.03 CMS Model Payments 2 1.04 Withholding Rights 4 Article II CLOSING DELIVERABLES 4 2.01 Closing 4 2.02 Buyer’s Closing D |
|
| November 18, 2024 |
Exhibit 99.1 CareMax Reaches Agreements to Sell Management Services Organization and Core Centers’ Assets Revere Medical Enters into Agreement to Acquire CareMax’s Management Services Organization Agreement in Principle Reached with “Stalking Horse” for Core Centers’ Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax’s Secured L |
|
| November 18, 2024 |
Exhibit 10.2 SUPERPRIORITY PRIMING DEBTOR-IN-POSSESSION CREDIT AGREEMENT dated as of November [], 2024 among CAREMAX, INC., a debtor and debtor-in-possession under Chapter 11 of the Bankruptcy Code, as the Borrower, THE OTHER GUARANTORS PARTY HERETO, debtors and debtors-in-possession under Chapter 11 of the Bankruptcy Code, as Guarantors, THE LENDERS PARTY HERETO, and ACQUIOM AGENCY SERVICES LLC, |
|
| November 18, 2024 |
Exhibit 10.4 Execution Version Confidential SERVICES AGREEMENT BY AND BETWEEN BRADY HEALTH BUYER, LLC AS PROVIDER AND CAREMAX, INC. AS RECIPIENT Dated as of November 17, 2024 TABLE OF CONTENTS SECTION 1 - EFFECTIVE DATE AND DEFINED TERMS 5 SECTION 2 - SERVICES 6 2.1 Services Generally 6 2.2 Data Integrity and Information Security Measures 7 2.3 Scope of Services 10 SECTION 3 - TERM 10 3.1 Term 10 |
|
| November 13, 2024 |
NT 10-Q 1 q32024-12b25.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number 001-39391 CUSIP Number 14171W202 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Tr |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 04, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| October 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 07, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 09, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 02, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| August 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| August 9, 2024 |
Exhibit 10.1 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND FOURTH AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND FOURTH AMENDMENT TO CREDIT AGREEMENT, dated as of May 14, 2024 (t |
|
| August 9, 2024 |
CareMax Reports Second Quarter 2024 Results EX-99.1 CareMax Reports Second Quarter 2024 Results • Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year • Second Quarter Total Revenue of $198.6 million, down 12% year-over-year Miami, FL - August 9, 2024 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results fo |
|
| August 9, 2024 |
Exhibit 10.3 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND SIXTH AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND SIXTH AMENDMENT TO CREDIT AGREEMENT, dated as of June 21, 2024 (th |
|
| August 9, 2024 |
Exhibit 10.4 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND SEVENTH AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND SEVENTH AMENDMENT TO CREDIT AGREEMENT, dated as of June 28, 2024 |
|
| August 9, 2024 |
Exhibit 10.2 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT, dated as of June 17, 2024 (th |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 08, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. |
|
| May 13, 2024 |
Exhibit 10.2 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND THIRD AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of March 15, 2024 (t |
|
| May 9, 2024 |
CareMax Reports First Quarter 2024 Results EX-99.1 CareMax Reports First Quarter 2024 Results • First Quarter Medicare Advantage Membership of 107,000, up 12% year-over-year • First Quarter Total Revenue of $232.2 million, up 34% year-over-year • Continuing to Explore Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity Miami, FL - May 9, 2024 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company” |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 09, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 9, 2024 |
Exhibit 10.2 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version LIMITED WAIVER AND THIRD AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of March 15, 2024 (t |
|
| May 9, 2024 |
Letter Agreement, dated March 14, 2024, by and between CareMax, Inc. and Kevin Wirges. EXHIBIT 10.1 CareMax, Inc. 1000 NW 57 Court, Suite 400 Miami, FL 33126 March 14, 2024 Mr. Kevin Wirges Dear Kevin: Given your position as Chief Financial Officer of CareMax, Inc. (the “Company”), you are key to the Company’s business and your continued employment is important to the Company’s future success. For purposes of this letter agreement (the “Agreement”), references to the “Company” shoul |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| May 9, 2024 | ||
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. |
|
| March 18, 2024 |
CareMax Reports Fourth Quarter and Full Year 2023 Results EX-99.1 CareMax Reports Fourth Quarter and Full Year 2023 Results • Met 2023 Guidance for Medicare Advantage Membership and Total Revenue • Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year • Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year • Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity Miami, FL - M |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39391 CareMax, Inc. |
|
| March 18, 2024 |
CareMax, Inc. Compensation Clawback Policy Exhibit 97.1 CAREMAX, INC. POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Introduction The Board of Directors (the “Board”) of CareMax, Inc. (the “Company”) has adopted this Policy on Recoupment of Incentive Compensation (this “Policy”), which provides for the recoupment of compensation in certain circumstances in the event of a restatement of financial results by the Company. This Policy shall be |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number 001-39391 CUSIP Number 14171W202 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| March 18, 2024 |
Exhibit 21.1 Subsidiaries Number of Omitted Subsidiaries Operating Name of Subsidiary State of Organization In the United States In Foreign Countries CareMax Medical Group, L.L.C. Florida 22 1 Managed Healthcare Partners L.L.C. Florida 0 0 Care Optimize LLC Delaware 0 1 IMC Medical Group Holdings, LLC Florida 7 0 CareMax Holdings, LLC Delaware 7 0 |
|
| February 14, 2024 |
CareMax Inc / EMINENCE CAPITAL, LP Passive Investment SC 13G/A 1 p24-0590sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 2 Under the Securities Exchange Act of 1934 CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CUSIP Number) December 31, 2023 (Date of event which requires filing of this statement) Check the appropriate box to |
|
| February 5, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CAREMAX, INC. CareMax, Inc. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, does hereby certify as follows: 1. This Certificate of Amendment amends the provisions of the Corporation’s Third Amended and Restated Certificate of Incorporation (the “Thir |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 29, 2024 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 29, 2024 |
CareMax Announces 1-for-30 Reverse Stock Split Exhibit 99.1 CareMax Announces 1-for-30 Reverse Stock Split Miami, FL - January 29, 2024 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced that the Company’s Board of Directors (the “Board”) has approved a 1-for-30 reverse stock split (the “Reverse Stock Split”) of its Class A common stock, par value $ |
|
| January 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to §240. |
|
| January 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 05, 2024 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| December 21, 2023 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 11, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid |
|
| November 9, 2023 |
Third Quarter 2023 Earnings Presentation November 9, 2023 EX-99.2 Third Quarter 2023 Earnings Presentation November 9, 2023 EX-99.2 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or any of its affiliates. The inform |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 09, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 9, 2023 |
CareMax Reports Third Quarter 2023 Results EX-99.1 CareMax Reports Third Quarter 2023 Results • Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year • Third Quarter Total Revenue of $201.8 million, up 28% year-over-year • Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance Miami, FL - November 9, 2023 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| October 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 05, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 11, 2023 |
August 11, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N. |
|
| August 9, 2023 |
CareMax Reports Second Quarter 2023 Results EX-99.1 CareMax Reports Second Quarter 2023 Results • Second Quarter Medicare Advantage Membership of 102,500, up 177% year-over-year • Second Quarter Total Revenue of $224.4 million, up 30% year-over-year • Raising Full Year 2023 Revenue Guidance; Reaffirming Full Year 2023 Adjusted EBITDA Guidance Miami, FL - August 9, 2023 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a le |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| August 9, 2023 |
Second Quarter 2023 Earnings Presentation August 9, 2023 EX-99.2 Second Quarter 2023 Earnings Presentation August 9, 2023 EX-99.2 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or any of its affiliates. The informa |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 09, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| June 27, 2023 |
June 27, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N. |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 17, 2023 |
As filed with the Securities and Exchange Commission on May 16, 2023 As filed with the Securities and Exchange Commission on May 16, 2023 Registration No. |
|
| May 17, 2023 |
Exhibit 107.1 CALCULATION OF FILING FEE TABLES Form S-8 (Form Type) CareMax, Inc. (Exact Name of registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price per Share (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Class A common stock, |
|
| May 15, 2023 |
May 15, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N. |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| May 10, 2023 |
[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 10, 2023 |
CAREMAX, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) CareMax Reports First Quarter 2023 Results • First Quarter Medicare Advantage Membership of 95,500, up 181% year-over-year • First Quarter Total Revenue of $173. |
|
| May 10, 2023 |
First Quarter 2023 Earnings Presentation May 10, 2023 First Quarter 2023 Earnings Presentation May 10, 2023 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 28, 2023 |
DEF 14A 1 d427362ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ |
|
| March 30, 2023 |
March 30, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N. |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39391 CareMax, Inc. |
|
| March 30, 2023 |
Exhibit 21.1 Subsidiaries Number of Omitted Subsidiaries Operating Name of Subsidiary State of Organization In the United States In Foreign Countries CareMax Medical Group, L.L.C. Florida 22 0 Managed Healthcare Partners L.L.C. Florida 0 0 Care Optimize LLC Delaware 0 1 IMC Medical Group Holdings, LLC Florida 7 0 CareMax Holdings, LLC Delaware 7 0 |
|
| March 30, 2023 |
Exhibit 4.4 CAREMAX, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED As of December 31, 2022, CareMax, Inc. (“we,” “our,” “us” or the “Company”) had the following two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) Class A common stock, $0.0001 par valu |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 2 l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. |
|
| March 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| March 13, 2023 |
CareMax Inc / DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13D-2(a) (Amendment No. 7) CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CU |
|
| March 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 13, 2023 |
Investor Day 2023 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 9, 2023 |
Fourth Quarter and Full Year 2022 Earnings Presentation March 9, 2023 Fourth Quarter and Full Year 2022 Earnings Presentation March 9, 2023 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 08, 2023 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 9, 2023 |
CareMax Reports Fourth Quarter and Full Year 2022 Results CareMax Reports Fourth Quarter and Full Year 2022 Results • Exceeded 2022 Guidance for Membership and Revenue and Met 2022 Guidance for Adjusted EBITDA (Inclusive of De Novo Pre-Opening Costs and Post-Opening Losses) • Year-end 2022 Medicare Advantage Membership of 93,500, up 179% year-over-year • Full Year 2022 Total Revenue of $631 million, up 113% year-over-year on a GAAP Basis, or up 57% on a |
|
| February 23, 2023 |
For the year ended December 31, 2021 February 23, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N. |
|
| February 14, 2023 |
CareMax Inc / Athyrium Opportunities III Acquisition 2 LP - SC 13G/A Passive Investment SC 13G/A 1 d293042dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 p |
|
| February 14, 2023 |
CareMax Inc / EMINENCE CAPITAL, LP - CAREMAX, INC. Passive Investment SC 13G/A 1 p23-0280sc13ga.htm CAREMAX, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 1 Under the Securities Exchange Act of 1934 CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CUSIP Number) December 31, 2022 (Date of event which requires filing of this statement) Check the appr |
|
| February 9, 2023 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-264654 PROSPECTUS CareMax, Inc. Up to 58,657,003 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the “S |
|
| January 31, 2023 |
Power of Attorney (included on the signature pages hereto). Table of Contents As filed with the U.S. Securities and Exchange Commission on January 31, 2023. Registration No. 333-264654 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 8000 85-099222 |
|
| January 17, 2023 |
For the Twelve Months Ended December 31, January 17, 2023 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N. |
|
| January 11, 2023 |
January 12, 2023 J.P. Morgan Healthcare Conference Exhibit 99.1 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or any of its affiliates. The informat |
|
| January 11, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 11, 2023 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 22, 2022 |
CareMax Inc / de la Torre Ralph - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* CareMax, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 14171W103 (CUSIP Number) Ralph de la Torre c/o Steward Health Care Investors LLC 1900 N. Pearl Street, Suite 2400 Dallas, TX 75201 (Name |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 17, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 14, 2022 |
Exhibit 10.4 AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This Amendment (this ?Amendment?) to that certain REGISTRATION RIGHTS AGREEMENT, dated as of July 13, 2021 (the ?Original Agreement?), by and among (i) CareMax, Inc., a Delaware corporation (?Pubco?), (ii) Related CM Advisor, LLC, a Delaware Limited Liability Company (the ?Advisor?), and (iii) each of the other Persons wh |
|
| November 14, 2022 |
Exhibit 99.1 CareMax, Inc. Completes Acquisition of Medicare Value-Based Care Business of Steward Health Care System Significantly expands CareMax?s comprehensive and coordinated healthcare delivery system designed to reduce healthcare costs, improve overall health outcomes, and promote health equity for seniors Miami, FL ? November 11, 2022 - CareMax, Inc. (NASDAQ: CMAX; CMAXW) (?CareMax? or the |
|
| November 14, 2022 |
Exhibit 3.1 Certificate of Designation of Series A Preferred Stock of CareMax, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware (the ?DGCL?), CareMax, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?Corporation?), in accordance with the provisions of Section 103 thereof, does hereby submit the following |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 14, 2022 |
Exhibit 10.1 Notwithstanding anything herein to the contrary, the liens and security interests granted to the Agent (as defined below) pursuant to this Agreement (as defined below) and the exercise of any right or remedy by the Agent or any Lender (as defined below) hereunder is subject to the limitations and provisions contained in the Subordination Agreement (as defined below). In the event of a |
|
| November 14, 2022 |
Exhibit 10.2 Execution Version [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. INVESTOR RIGHTS AGREEMENT This INVESTOR RIGHTS AGREEMENT (this ?Agreement?) is made as of November 10, 2022, by and among CareMax, Inc., a Delawa |
|
| November 14, 2022 |
Exhibit 10.3 AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This Amendment (this ?Amendment?) to that certain AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, dated as of December 18, 2020 (the ?Original Agreement?), by and among (i) CareMax, Inc., f/k/a Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (?Pubco?), (ii) DFHTA Sponsor LLC, a Delaware limi |
|
| November 14, 2022 |
Exhibit 10.5 Execution Version CONSENT AND FIRST AMENDMENT TO CREDIT AGREEMENT THIS CONSENT AND FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of November 10, 2022 (this ?Agreement?), is made by and among CareMax, Inc. (the ?Borrower?), the Subsidiary Guarantors, the Lenders party hereto and Jefferies Finance LLC, as administrative agent (in such capacity, the ?Administrative Agent?) and collateral |
|
| November 9, 2022 |
CareMax, Inc. Reports Third Quarter 2022 Results; Raises Full Year Revenue Outlook EX-99.1 CareMax, Inc. Reports Third Quarter 2022 Results; Raises Full Year Revenue Outlook ? Third Quarter 2022 Medicare Advantage Membership of 39,500, up 49% year-over-year ? Third Quarter 2022 GAAP Total Revenue of $157.7 million, up 51% year-over-year ? Expanded Presence with De Novo Openings in Brooklyn, New York; Queens, New York; and Plantation, Florida Since Quarter End ? Raising Full Year |
|
| November 9, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-264654 PROSPECTUS SUPPLEMENT NO. 3 (to prospectus dated May 18, 2022) CareMax, Inc. Up to 63,581,530 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained in the pro |
|
| November 9, 2022 |
Third Quarter 2022 Earnings Presentation November 9, 2022 EX – 99.2 Third Quarter 2022 Earnings Presentation November 9, 2022 EX ? 99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The info |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| November 7, 2022 |
CareMax Inc / DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13D-2(a) (Amendment No. 6) CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CU |
|
| November 3, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 7, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| August 10, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-264654 PROSPECTUS SUPPLEMENT NO. 2, amended as of August 9, 2022* (to prospectus dated May 18, 2022) CareMax, Inc. Up to 63,581,530 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the i |
|
| August 9, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-264654 PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated August 9, 2022) CareMax, Inc. Up to 63,581,530 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained in the p |
|
| August 9, 2022 |
EX-99.1 CareMax, Inc. Reports Second Quarter 2022 Results; Raises Full Year Medicare Advantage Membership and Revenue Outlook ? Second Quarter 2022 Medicare Advantage Membership of 37,000, up 72% year-over-year ? Second Quarter 2022 GAAP Total Revenue of $172.3 million, up 284% year-over-year, or up 87% on a Pro Forma Basis1 ? Expanded Presence with De Novo Openings in Houston, Texas; Brooklyn, Ne |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| August 9, 2022 |
Second Quarter 2022 Earnings Presentation August 9, 2022 EX-99.2 Second Quarter 2022 Earnings Presentation August 9, 2022 EX-99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The informa |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 8, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| June 2, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-264654 PROSPECTUS SUPPLEMENT NO. 1 (to prospectus dated May 18, 2022) CareMax, Inc. Up to 63,581,530 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained in the pro |
|
| June 2, 2022 |
CMAX / CareMax, Inc. Class A / DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13D-2(a) (Amendment No. 5) CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 244413 100 (C |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 1, 2022 |
EX-10.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG CAREMAX, INC., SPARTA MERGER SUB I LLC, SPARTA MERGER SUB II LLC, SPARTA MERGER SUB III LLC, SPARTA MERGER SUB I INC., SPARTA MERGER SUB II INC., SPARTA MERGER SUB III INC., SPARTA SUB, INC., SNCN HOLDCO INC., SICN HOLDCO INC., STEWARD HEALTH CARE SYSTEM LLC AND SPARTA HOLDING CO. LLC May 31, 2022 Table of Contents Article I THE MERGER 2 1.01 Merge |
|
| June 1, 2022 |
Steward Value-Based Care Acquisition Investor Presentation June 1, 2022 EX-99.2 Steward Value-Based Care Acquisition Investor Presentation June 1, 2022 EX-99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential acquisition of the value-based care business of Steward Health Care System by CareMax, Inc. (?CareMax? or the ?Compa |
|
| June 1, 2022 |
CareMax, Inc. to Acquire Medicare Value-Based Care Business of Steward Health Care System EX-99.1 CareMax, Inc. to Acquire Medicare Value-Based Care Business of Steward Health Care System ? Transaction to expand CareMax?s comprehensive and coordinated healthcare delivery system designed to improve overall health outcomes for senior value-based care patients ? Brings CareMax?s high-quality, whole person healthcare to underserved communities with a focus on patients' social determinants |
|
| June 1, 2022 |
DEFA14A 1 defa14a-employeeannou.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted b |
|
| June 1, 2022 |
EX-10.2 SUPPORT AGREEMENT This SUPPORT AGREEMENT, dated as of May 31, 2022 (this ?Agreement?), is entered into by Deerfield Partners, L.P. (?Stockholder?) and CareMax, Inc., a Delaware corporation (the ?Company?). Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below). WHEREAS, the Company is party to that certai |
|
| June 1, 2022 |
Steward Value-Based Care Acquisition Investor Presentation June 1, 2022 EX-99.2 Steward Value-Based Care Acquisition Investor Presentation June 1, 2022 EX-99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential acquisition of the value-based care business of Steward Health Care System by CareMax, Inc. (?CareMax? or the ?Compa |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 1, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Com |
|
| May 20, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-264654 Prospectus CareMax, Inc. Up to 63,581,530 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the ?Selling Sec |
|
| May 18, 2022 |
Table of Contents As filed with the U.S. Securities and Exchange Commission May 17, 2022. Registration No. 333-264654 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 8000 85-0992224 (State or other jurisdiction of |
|
| May 18, 2022 |
Exhibit 10.24 [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. CREDIT AGREEMENT dated as of May 10, 2022, among CAREMAX, INC., as the Borrower, THE OTHER GUARANTORS PARTY HERETO, as Guarantors, THE LENDERS AND ISSUING BANKS P |
|
| May 18, 2022 |
May 18, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Abby Adams Re: CareMax, Inc. Registration Statement on Form S-1 File No. 333-264654 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, CareMax, Inc., a Delaware corporation (the ?Company?), hereby requests acceleration |
|
| May 16, 2022 |
May 16, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Abby Adams Re: CareMax, Inc. Registration Statement on Form S-1 File No. 333-264654 Ladies and Gentlemen: CareMax, Inc., a Delaware corporation (the ?Company?), hereby requests that the U. S. Securities and Exchange Commission take appropriate action to wit |
|
| May 12, 2022 |
May 12, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Abby Adams Re: CareMax, Inc. Registration Statement on Form S-1 File No. 333-264654 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, CareMax, Inc., a Delaware corporation (the ?Company?), hereby requests acceleration |
|
| May 10, 2022 |
First Quarter 2022 Earnings Presentation May 10, 2022 EX – 99.2 First Quarter 2022 Earnings Presentation May 10, 2022 EX ? 99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The informat |
|
| May 10, 2022 |
First Quarter 2022 Earnings Presentation May 10, 2022 EX – 99.2 EX-99.2 3 cmax-ex992.htm EX-99.2 First Quarter 2022 Earnings Presentation May 10, 2022 EX – 99.2 Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or an |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| May 10, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2022 |
CareMax, Inc. Announces First Quarter 2022 Financial Results EX-99.1 CareMax, Inc. Announces First Quarter 2022 Financial Results ? First Quarter 2022 Medicare Advantage Membership of 34,000, up 106% year-over-year1 ? First Quarter 2022 GAAP Total Revenue of $136.9 million, up 390% Compared to First Quarter 2021 Total Revenue of $27.9 Million, or up 55% on a Pro Forma Basis1 ? Reaffirms Full Year 2022 Guidance ? Entered into a $300.0 million Credit Agreemen |
|
| May 4, 2022 |
Table of Contents As filed with the U.S. Securities and Exchange Commission May 4, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 8000 85-0992224 (State or other jurisdiction of incorporation or organizat |
|
| May 4, 2022 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) CareMax, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly |
|
| May 4, 2022 |
Exhibit 4.1 SEE REVERSE FOR IMPORTANT NOTICE REGARDING OWNERSHIP AND TRANSFER RESTRICTIONS AND CERTAIN OTHER INFORMATION INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON SHARES CUSIP 14171W 10 3 THIS CERTIFIES THAT SPECIMEN IS THE OWNER OF FULLY PAID AND NON-ASSESSABLE SHARES OF CLASS A COMMON SHARES, $0.0001 VALUE PER SHARE, OF CareMax, Inc. transferable on the books of the Cor |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. 1 0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K/A Amendment No. |
|
| March 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 16, 2022 |
Exhibit 21.1 Subsidiaries Number of Omitted Subsidiaries Operating Name of Subsidiary State of Organization In the United States In Foreign Countries CareMax Medical Group, L.L.C. Florida 22 0 Managed Healthcare Partners L.L.C. Florida 0 0 Care Optimize LLC Delaware 0 1 IMC Medical Group Holdings, LLC Florida 7 0 |
|
| March 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| March 16, 2022 |
Exhibit 4.4 CAREMAX, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED AS OF DECEMBER 31, 2021 As of December 31, 2021, CareMax, Inc. (?we,? ?our,? ?us? or the ?Company?) had the following two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (i) Class A common |
|
| March 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39391 CareMax, Inc. |
|
| March 8, 2022 |
CareMax Inc. Announces Fourth Quarter and Full Year 2021 Financial Results EX-99.1 CareMax Inc. Announces Fourth Quarter and Full Year 2021 Financial Results ? Year-end 2021 Medicare Advantage Membership of 33,500, up 103% year-over-year ? Full Year 2021 GAAP Total Revenue of $295.8 million, up 186% year-over-year1; Pro Forma Revenue of $403.3 million, up 20% year-over-year2 ? 2022 Medicare Advantage Membership Expected to Grow 13% to 19% ? Expanded Presence with De Novo |
|
| March 8, 2022 |
Fourth Quarter and Full Year 2021 Earnings Presentation March 8, 2022 EX-99.2 Fourth Quarter and Full Year 2021 Earnings Presentation March 8, 2022 EX-99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates |
|
| March 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 7, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number |
|
| February 16, 2022 |
Letter of WithumSmith+Brown, PC dated February 16, 2022. EX ? 16.1 February 16, 2022 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Ladies and Gentlemen: We have read the statements of CareMax, Inc. under Item 4.01 of its Form 8-K dated February 16, 2022. We agree with the statements concerning our Firm under Item 4.01, in which we were informed of our dismissal on February 11, 2022. We are not |
|
| February 16, 2022 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 11, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 15, 2022 |
CMAX / CareMax, Inc. Class A / DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13D-2(a) (Amendment No. 4) CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 244413 100 (C |
|
| February 14, 2022 |
CareMax Inc / EMINENCE CAPITAL, LP - CAREMAX, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CUSIP Number) December 31, 2021 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 11, 2022 |
CareMax Inc / Athyrium Opportunities III Acquisition 2 LP - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14 |
|
| February 7, 2022 |
CareMax, Inc. Announces Board Leadership Transition EX-99.1 FOR IMMEDIATE RELEASE CareMax, Inc. Announces Board Leadership Transition MIAMI, FL ? February 7, 2022 ? CareMax, Inc. (?CareMax?) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, today announced the appointment of Mr. Jose R. Rodriguez as Chair of CareMax?s board of directors, to succeed Mr. Richard A. Barasch, who has resigned from the Board. M |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 28, 2022 |
CMAX / CareMax, Inc. Class A / DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13D-2(a) (Amendment No. 3) CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 244413 100 (C |
|
| January 13, 2022 |
J.P. Morgan 2022 Virtual Healthcare Conference January 13, 2022 EX – 99.1 J.P. Morgan 2022 Virtual Healthcare Conference January 13, 2022 EX ? 99.1 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. Th |
|
| January 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 13, 2022 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 5, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| January 5, 2022 |
Exhibit 10.1 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of December 30, 2021 (this ?Agreement?), is made by and among CareMax, Inc. (f/k/a Deerfield Healthcare Technology Acquisitions Corp.) (the ?Borrower?), the Lenders (such capitalized term and all other capitalized terms not otherwise defined herein shall have the meanings set forth |
|
| December 17, 2021 |
EX-10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) is entered into this 13th day of December, 2021 (the ?Effective Date?) by and between Managed Healthcare Partners, LLC, a Florida limited liability company (the ?Employer?), and Alberto de Solo (the ?Executive?). WHEREAS, Employer desires to continue employing Executive, and Executive desires to continue |
|
| December 17, 2021 |
EX-10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) is entered into this 13th day of December, 2021 (the ?Effective Date?) by and between Managed Healthcare Partners, LLC, a Florida limited liability company (the ?Employer?), and Kevin Wirges (the ?Executive?). WHEREAS, Employer desires to continue employing Executive, and Executive desires to continue pro |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 17, 2021 |
EX-10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) is entered into this 13th day of December, 2021 (the ?Effective Date?) by and between Managed Healthcare Partners, LLC, a Florida limited liability company (the ?Employer?), and Carlos A. de Solo (the ?Executive?). WHEREAS, the Company desires to continue employing Executive, and Executive desires to cont |
|
| November 15, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257574 PROSPECTUS SUPPLEMENT NO. 3 (to prospectus dated July 15, 2021) CareMax, Inc. Up to 72,657,457 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained in the pr |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 15, 2021 |
Third Quarter 2021 Earnings Presentation November 15, 2021 EX-99.2 Third Quarter 2021 Earnings Presentation November 15, 2021 EX-99.2 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The infor |
|
| November 15, 2021 |
CareMax Inc. Announces Third Quarter 2021 Financial Results EX-99.1 CareMax Inc. Announces Third Quarter 2021 Financial Results Miami, FL - November 15, 2021 - CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Results1 ? GAAP total revenue was $104.6 million for the third quarter of 2021 and $177.5 mi |
|
| October 25, 2021 |
As filed with the Securities and Exchange Commission on October 25, 2021 As filed with the Securities and Exchange Commission on October 25, 2021 Registration No. |
|
| October 25, 2021 |
EX - 10.4 Incentive Stock Option Agreement Under the CareMax, Inc. 2021 Long-Term Incentive Plan 1. Terminology. Capitalized terms used in this Agreement are defined in the correlating Stock Option Notice and/or the Glossary at the end of the Agreement or in the Plan. 2. Exercise of Options. (a) Exercisability. The Options will become exercisable in accordance with the Exercisability Schedule set |
|
| October 25, 2021 |
EX - 10.3 CareMax, Inc. Restricted Stock Units Agreement under the CareMax, Inc. 2021 Long-Term Incentive Plan 1. Terminology. Unless otherwise provided in this Agreement, capitalized terms used herein are defined in the Glossary at the end of this Agreement. 2. Vesting. All of the RSUs are nonvested and forfeitable as of the Grant Date. So long as your Service is continuous from the Grant Date th |
|
| October 25, 2021 |
EX - 10.2 Nonstatutory Stock Option Agreement Under the CAREMAX, Inc. 2021 LONG-TERM Incentive Plan 1. Terminology. Capitalized terms used in this Agreement are defined in the correlating Stock Option Notice and/or the Glossary at the end of the Agreement or in the Plan. 2. Exercise of Options. (a) Exercisability. The Options will become exercisable in accordance with the Exercisability Schedule s |
|
| October 25, 2021 |
EX - 10.5 Restricted Stock Agreement under the CareMax, Inc. 2021 Long-Term Incentive Plan Grantee: No. of Shares: This Agreement (the ?Agreement?) evidences the award of restricted shares (each, an ?Award Share,? and collectively, the ?Award Shares?) of the common stock of CareMax, Inc., a Delaware corporation (the ?Company?), granted to you, , effective as of (the ?Grant Date?), pursuant to the |
|
| October 6, 2021 |
EX-10.1 SEPARATION AND RELEASE AGREEMENT This SEPARATION AND RELEASE AGREEMENT (the ?Agreement?) is made and entered into this 30th day of September, 2021 (the ?Effective Date?) by and between William C. Lamoreaux, a citizen and resident of Florida (hereinafter ?Executive?), and CareMax, Inc., a Delaware corporation (?CareMax?), together with its subsidiaries, including, without limitation, IMC Me |
|
| October 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 24, 2021 |
CareMax Inc / O.M. Investment Group, Inc. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* CAREMAX, INC. (Name of Issuer) CLASS A COMMON STOCK, $0.0001 PAR VALUE PER SHARE (Title of Class of Securities) 14171W103 (CUSIP Number) CARLOS A. DE SOLO 1000 NW 57 COURT, SUITE 400 MIAMI, FLORIDA 33126 (786) 360-4768 O.M. INVESTMENT GROUP, INC. 1000 NW 57 COURT, S |
|
| September 20, 2021 |
CareMax, Inc. Appoints Beatriz Assapimonwait to Board of Directors EXHIBIT-99.1 FOR IMMEDIATE RELEASE CareMax, Inc. Appoints Beatriz Assapimonwait to Board of Directors MIAMI, FL (Sept. 20, 2021) ? CareMax, Inc. (?CareMax?) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, today announced that Beatriz Assapimonwait has been appointed as an independent member of the CareMax board of directors. Ms. Assapimonwait brings to |
|
| September 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 20, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 9, 2021 |
Analyst and Investor Day Presentation September 9, 2021 EX-99.1 Analyst and Investor Day Presentation September 9, 2021 EX-99.1 Disclaimer Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The informat |
|
| September 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 7, 2021 |
CareMax, Inc. Appoints Dr. Vincent Omachonu to Board of Directors EX-99.1 FOR IMMEDIATE RELEASE CareMax, Inc. Appoints Dr. Vincent Omachonu to Board of Directors MIAMI, FL - Sept. 7, 2021 ? CareMax, Inc. (?CareMax?) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, today announced that Dr. Vincent Omachonu has been appointed as an independent member of the CareMax board of directors. ?We are very pleased to have Dr. Oma |
|
| September 2, 2021 |
CareMax Closes Acquisition of DNF Medical Centers EX-99.1 2 cmax-20210901ex991.htm EX-99.1 EX-99.1 CareMax Closes Acquisition of DNF Medical Centers Miami, FL – Sept. 2, 2021 - CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW) , a leading technology-enabled provider of value-based care to seniors, announced today that it has closed the previously announced acquisition of DNF Medical Centers (“DNF”), a leading medical practice in the Orlando Metro a |
|
| September 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 26, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257574 PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated July 15, 2021) CareMax, Inc. Up to 72,657,457 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained in the pr |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| August 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39391 CareMax, Inc. |
|
| August 18, 2021 |
424(b)(3) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257574 PROSPECTUS SUPPLEMENT NO. 1 (to prospectus dated July 15, 2021) CareMax, Inc. Up to 72,657,457 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants This prospectus supplement is being filed to update and supplement the information contained |
|
| August 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| August 16, 2021 |
CareMax Inc. Announces Second Quarter 2021 Financial Results Exhibit 99.1 CareMax Inc. Announces Second Quarter 2021 Financial Results Miami, FL ? August 13, 2021 ? CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today financial results for the second quarter ended June 30, 2021. Business Highlights ? Announced collaboration with Anthem described in separate press release issued earlier to |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2021 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) ( |
|
| August 13, 2021 |
CareMax Inc. Announces Second Quarter 2021 Financial Results Exhibit 99.1 CareMax Inc. Announces Second Quarter 2021 Financial Results Miami, FL ? August 13, 2021 - CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today financial results for the second quarter ended June 30, 2021. Business Highlights ? Announced collaboration with Anthem described in separate press release issued earlier to |
|
| August 13, 2021 |
CareMax Signs Collaboration Agreement with Anthem Exhibit 99.3 CareMax Signs Collaboration Agreement with Anthem ? CareMax to open approximately 50 medical centers across eight states through programmatic relationship with Anthem ? Anthem to collaborate with CareMax to improve outcomes and quality for NYC municipal employee retirees Miami, FL ? August 13, 2021 - CareMax, Inc. (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-b |
|
| August 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2021 CareMax, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39391 85-0992224 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 13, 2021 |
Second Quarter 2021 ? Earnings Presentation Exhibit 99.2 Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The information contained here |
|
| July 16, 2021 |
TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(3) ?Registration No. 333-257574? CareMax, Inc. Up to 72,657,457 Shares of Class A Common Stock Up to 5,791,667 Shares of Class A Common Stock Issuable Upon Exercise of Warrants and Up to 2,916,667 Warrants ? This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the ?Selling Securityh |
|
| July 13, 2021 |
Exhibit 99.2 Transaction with Related Companies July 13, 2021 1 2 Presentation This presentation (?Presentation?) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (?CareMax? or the ?Company?) or any of its affiliates. The Presentation has |
|
| July 13, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: July 13, 2021 CAREMAX ENTERS INTO EXCLUSIVE AGREEMENT WITH RELATED COMPANIES TO SUPPORT CAREMAX IN OPENING MEDICAL CENTERS IN SENIOR AFFORDABLE HOUSING THROUGHOUT THE U.S. ? The Agreement is Designed to Support CareMax in Bringing Convenient, Comprehensive Value-Based Healthcare to Inhabitants of Senior Affordable Housing Across the Country ? Expected to Acceler |
|
| July 13, 2021 |
Exhibit 10.1 [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is both not material and is the type that the registrant treats as private or confidential. EXCLUSIVE REAL ESTATE ADVISORY AGREEMENT THIS EXCLUSIVE REAL ESTATE ADVISORY AGREEMENT (this ?Agreement?), dated as of July 13, 2021 (the ?Effective Date?), is by |
|
| July 13, 2021 |
CORRESP 1 filename1.htm July 13, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ada D. Sarmento Re: CareMax, Inc. Registration Statement on Form S-1 File No. 333-257574 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, CareMax, Inc., a Delaware corporation (the “Company”), |
|
| July 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 13, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 7, 2021 |
Exhibit 99.1 CareMax Enters into Agreement to Acquire DNF Medical Centers to Further Expand Central Florida Presence Acquisition Will Add Six Medical Centers and More Than 4,000 Medicare Advantage Members Miami, FL ? July 6, 2021 - CareMax, Inc. (?CareMax?) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today it has entered into a definitive |
|
| July 7, 2021 |
Exhibit 10.1 [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is both not material and is the type that the registrant treats as private or confidential. ASSET PURCHASE AGREEMENT BY AND AMONG UNLIMITED MEDICAL SERVICES OF FLORIDA, LLC, THE ESTATE OF NORBERTO FLEITES, Caremax Medical Centers of Central Florida, LLC, |
|
| July 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 5, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 30, 2021 |
As filed with the U.S. Securities and Exchange Commission on June 30, 2021. TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on June 30, 2021. Registration No. 333-?????????? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933? CareMax, Inc. (Exact name of registrant as specified in its charter) ? Delaware (State or other jurisdiction of incorporation or org |
|
| June 21, 2021 |
CMAX / CareMax, Inc. Class A / IMC Holdings, LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CareMax, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 14171W103 (CUSIP Number) June 8, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| June 21, 2021 |
CMAX / CareMax, Inc. Class A / O.M. Investment Group, Inc. - SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* Caremax, INC. (Name of Issuer) Common Stock, $0.0001 Par Value Per Share (Title of Class of Securities) 14171W103 (CUSIP Number) CARLOS A. DE SOLO 1000 NW 57 COURT, SUITE 400 MIAMI, FLORIDA 33126 (786) 360-4768 O.M. INVESTMENT GROUP, INC. 1000 NW 57 COURT, SUITE 400 MIA |
|
| June 21, 2021 |
Exhibit 99.1 CareMax Acquires Senior Medical Associates to Further Expand Broward County Presence Acquisition Adds 10 Medical Centers and Approximately 5,000 Medicare Advantage Members Miami, FL ? June 21, 2021 - CareMax, Inc. (?CareMax?) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today the closing of the acquisition of Senior Medical Ass |
|
| June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 18, 2021 CareMax, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39391 85-0992224 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 21, 2021 |
Exhibit 2.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this ?Agreement?) is entered into as of March 8, 2021, by and among Interamerican Medical Center Group, LLC, a Florida limited liability company (the ?Buyer?), Mohsin Jaffer (the ?Seller?), Senior Medical Associates, LLC, a Florida limited liability company (?SMA?), and Stallion Medical Management, LLC, a Florida limited |
|
| June 14, 2021 |
CAREMAX MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Exhibit 99.1 CAREMAX MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Unless the context otherwise requires, references in this section to ?CareMax,? ?we,? ?us,? ?our,? and the ?Company? refers to CareMax Medical Group, LLC and its subsidiaries. The following discussion and analysis summarizes the significant factors affecting the consolidated operating results |
